Loading…
Lobbying Spend
—
Filings
47
Firms Hired
1
Active Period
2016–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: CAPITOL COUNSEL LLC
Maintaining the treatment of advertising as a fully deductible ordinary and necessary business expense. Monitor issues related to H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: CAPITOL COUNSEL LLC
Maintaining the treatment of advertising as a fully deductible ordinary and necessary business expense. Monitor issues related to H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $290,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: CAPITOL COUNSEL LLC
Maintaining the treatment of advertising as a fully deductible ordinary and necessary business expense. Monitor issues related to H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: —
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Maintaining the treatment of advertising as a fully deductible ordinary and necessary business expense. Monitor issues related to H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: CAPITOL COUNSEL LLC
Maintaining the treatment of advertising as a fully deductible ordinary and necessary business expense. Monitor issues related to H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CAPITOL COUNSEL LLC
Maintaining the treatment of advertising as a fully deductible ordinary and necessary business expense; monitor issues related to Tax Cuts and Jobs Act (TCJA) P.L. 115-97 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
Responsibility in Drug Advertising Act of 2019
2020 · fourth_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.4106
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4711
Drug-price Transparency in Communications (DTC) Act
2020 · fourth_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.1437
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.1801
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
2020 · fourth_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.2550
End Taxpayer Subsidies for Drug Ads Act
2020 · fourth_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.73
Responsibility in Drug Advertising Act of 2019
2020 · third_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.4106
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4711
Drug-price Transparency in Communications (DTC) Act
2020 · third_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.1437
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.1801
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
2020 · third_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.2550
End Taxpayer Subsidies for Drug Ads Act
2020 · third_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $50,000
Matched citations: S.73
Responsibility in Drug Advertising Act of 2019
2020 · second_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $100,000
Matched citations: H.R.4106
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $100,000
Matched citations: H.R. 4711
Drug-price Transparency in Communications (DTC) Act
2020 · second_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $100,000
Matched citations: S.1437
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $100,000
Matched citations: S.1801
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
2020 · second_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $100,000
Matched citations: S.2550
End Taxpayer Subsidies for Drug Ads Act
2020 · second_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $100,000
Matched citations: S.73
Responsibility in Drug Advertising Act of 2019
2020 · first_quarter · Firm: Polsinelli PC
FTC Reauthorization Act of 2019 (Not introduced) S.73, End Taxpayer Subsidies for Drug Ads Act S.1437, Drug-price Transparency in Communications (DTC) Act H.R.4106, Responsibility in Drug Advertising Act H.R. 4711 - No Tax Breaks for Drug Ads Act S.2550 - No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.1801 - Affordable Medications Act
Client expense: — · Firm income: $120,000
Matched citations: H.R.4106
Source: Senate LDA